Cefoperazone Tazobactam Injection, marketed as Ciflozone-TZ, combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor. It effectively treats severe bacterial infections by disrupting cell wall synthesis and neutralizing beta-lactamase enzymes, thereby overcoming resistance. Administered intravenously, Ciflozone-TZ provides broad-spectrum coverage against Gram-positive and Gram-negative organisms. It is prescribed in serious infections where its dual mechanism enhances treatment efficacy, under the supervision of healthcare professionals.Available in PCD Franchise for injectable range and third party manufacturing.